Skip to main content
. 2021 Dec 7;23(2):121. doi: 10.3892/etm.2021.11044

Figure 1.

Figure 1

Dynamic changes in clinical parameters in all patients receiving ulinastatin treatment. (A) WBC count, (B) percentage of L and (C) hypersensitive CRP levels before ulinastatin treatment, and 3 and 7 days post-ulinastatin treatment. **P<0.05, repeated measures ANOVA. (D) Concentration of oxygen inhalation and (E) SaO2 before and after ulinastatin treatment. ***P<0.001, paired Student's t-test. WBC, white blood cell; L, lymphocyte; CRP, C-reactive protein; SaO2, oxygen saturation.